ERS Research Seminars
Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Courses and events
From anti-PD1/L1 inhibitors to new immunotherapies
Thierry Berghmans (Belgium)
New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thierry Berghmans (Belgium). From anti-PD1/L1 inhibitors to new immunotherapies. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
A 21-year-old male with high grade fever intermittent with chills
A 51-year-old nursing officer with moderate degree of fever and constitutional symptoms
ERS Handbook of Paediatric Respiratory Medicine - 2nd edition - CME test